Study guide
3.1 Resuscitation Fluids: Crystalloids vs. Colloids
Board Certified Critical Care Pharmacist Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pathophysiology and Recognition of Critical Illness
1.1 Pathophysiology of Shock and Sepsis 1.2 Respiratory Failure and ARDS Pathophysiology 1.3 ICU-Acquired Weakness and Post-Intensive Care Syndrome 1.4 Chronic Disease States and Risk Factors for Critical Illness
2 Chapter 2: Medical Devices and Circulatory Support
2.1 Hemodynamic Monitoring and Interpretation 2.2 Mechanical Circulatory Support 2.3 Mechanical Ventilation Modes and Settings 2.4 Continuous Renal Replacement Therapy 2.5 Lines, Tubes, and Drains in Critical Care
3 Chapter 3: Fluid, Electrolyte, and Acid-Base Management
3.1 Resuscitation Fluids: Crystalloids vs. Colloids 3.2 Electrolyte Disorders in the ICU 3.3 Acid-Base Disorders and Interpretation
4 Chapter 4: Vasoactive and Inotropic Therapy in Shock
4.1 Vasopressors in Distributive Shock 4.2 Inotropes and Vasopressors in Cardiogenic and Obstructive Shock
5 Chapter 5: Sedation, Analgesia, and Delirium (PADIS)
5.1 Pain and Analgesia in the ICU 5.2 Sedation Strategies and Medication Selection 5.3 Delirium Assessment, Prevention, and Treatment 5.4 Neuromuscular Blockade in Critical Illness
6 Chapter 6: Cardiovascular Emergencies
6.1 Acute Coronary Syndromes in ICU Patients 6.2 Acute Decompensated Heart Failure 6.3 Hypertensive Emergencies and Arrhythmias
7 Chapter 7: Pulmonary and Infectious Diseases in the ICU
7.1 Severe Sepsis and Septic Shock Antimicrobial Selection 7.2 Pharmacotherapy for Mechanical Ventilation and ARDS 7.3 Severe Infections in the ICU
8 Chapter 8: Neurocritical Care
8.1 Ischemic and Hemorrhagic Stroke Management 8.2 Intracranial Hypertension and Brain Edema 8.3 Status Epilepticus and Sedation in Brain Injury
9 Chapter 9: Toxicology, Endocrine, and Hematologic Emergencies
9.1 Toxicology and Antidote Therapy in the ICU 9.2 Endocrine Emergencies 9.3 Hematologic Emergencies, Anticoagulant Reversal, and Transfusions 9.4 Gastrointestinal and Hepatic Emergencies in the ICU 9.5 Dermatologic and Immunologic Conditions in the ICU 9.6 Trauma, Burns, Supportive Care, and End-of-Life Pharmacotherapy
10 Chapter 10: Special Populations, Pharmacokinetics, and Nutrition
10.1 Altered Pharmacokinetics in Critically Ill Patients 10.2 Therapeutic Drug Monitoring in the ICU 10.3 Nutrition Support: Enteral vs. Parenteral
11 Chapter 11: Quality, Safety, and Clinical Guidelines
11.1 Medication Safety and Error Prevention in the ICU 11.2 Antimicrobial Stewardship and Infection Prevention 11.3 Implementation of Clinical Practice Guidelines 11.4 Healthcare Regulations, Standards, and Drug Interactions
12 Chapter 12: Practice Management, Biostatistics, and Evidence-Based Medicine
12.1 ICU Formulary Management and Cost-Effectiveness 12.2 Biostatistics and Literature Evaluation 12.3 Clinical Trial Interpretation in Critical Care 12.4 Professional Development, Precepting, and ICU Pharmacy Services 12.5 Alternative ICU Delivery Models and Disaster Healthcare Management
13 Chapter 13: Treatment Planning and Care Coordination
13.1 Goals of Care, Perioperative Care, and Transitions of Care 13.2 Medication Delivery Routes and Devices in Critical Illness 13.3 Social Determinants of Health and Patient/Caregiver Education
3.1 Resuscitation Fluids: Crystalloids vs. Colloids
Key Takeaways Explain This Topic AI
Balanced crystalloids (e.g., Lactated Ringer's, Plasma-Lyte) are generally preferred over 0.9% sodium chloride for large-volume resuscitation in critically ill patients to reduce the risk of hyperchloremic metabolic acidosis and acute kidney injury.
0.9% sodium chloride (Normal Saline) is the resuscitation fluid of choice for patients with traumatic brain injury (TBI) and patients with hypochloremic metabolic alkalosis.
Albumin is a safe and effective colloid but should typically be reserved for patients requiring massive crystalloid resuscitation or those with liver disease/cirrhosis (e.g., large-volume paracentesis, hepatorenal syndrome).
Hydroxyethyl starches (HES) are contraindicated in critically ill patients due to a well-documented increased risk of acute kidney injury, need for renal replacement therapy, and mortality.
Last updated: July 2026
Resuscitation Fluids: Crystalloids vs. Colloids
Fluid resuscitation is one of the most common and critical interventions performed in the intensive care unit (ICU). The goal of fluid therapy is to restore intravascular volume, improve cardiac output, and ensure adequate tissue perfusion and oxygen delivery. However, intravenous fluids are drugs, each with a specific composition, indication, and adverse effect profile. Understanding the nuances of different resuscitation fluids is essential for the Board Certified Critical Care Pharmacist (BCCCP).
Intravenous Fluid Compartments
To understand fluid resuscitation, one must first understand how fluid distributes in the body. Total body water (TBW) accounts for approximately 60% of lean body weight. TBW is divided into two main compartments:
Intracellular Fluid (ICF): Accounts for two-thirds (67%) of TBW.
Extracellular Fluid (ECF): Accounts for one-third (33%) of TBW. The ECF is further subdivided into:
Interstitial Fluid: Three-quarters (75%) of ECF.
Intravascular Fluid (Plasma): One-quarter (25%) of ECF.
When a crystalloid solution is administered, it distributes throughout the ECF based on sodium content. Because the ECF is 75% interstitial and 25% intravascular, only about 25% of an administered isotonic crystalloid bolus remains in the intravascular space after equilibration (usually within 20-30 minutes). Colloids, owing to their large molecular weight, remain primarily in the intravascular space for a longer duration, exerting oncotic pressure.
Crystalloids
Crystalloids are aqueous solutions of mineral salts or other water-soluble molecules. They are the first-line therapy for the majority of critically ill patients requiring fluid resuscitation.
0.9% Sodium Chloride (Normal Saline)
Despite its name, "Normal Saline" (NS) is not physiologically normal. It contains 154 mEq/L of sodium and 154 mEq/L of chloride, resulting in an osmolarity of 308 mOsm/L. This chloride concentration is significantly higher than the normal plasma chloride level (98-106 mEq/L).
Advantages: Inexpensive, widely available, compatible with most medications (including blood products).
Disadvantages: Large volume administration reliably causes hyperchloremic non-anion gap metabolic acidosis . The high chloride load can cause renal afferent arteriole vasoconstriction, reducing glomerular filtration rate (GFR) and increasing the risk of acute kidney injury (AKI).
Primary Indications: Traumatic brain injury (TBI) to avoid cerebral edema (NS is slightly hypertonic compared to plasma), hypovolemic hyponatremia, and hypochloremic metabolic alkalosis (e.g., from severe vomiting or excessive diuresis).
Balanced Crystalloids
Balanced crystalloids are designed to more closely mimic the electrolyte composition of human plasma. Examples include Lactated Ringer's (LR) and Plasma-Lyte A. They contain lower concentrations of sodium and chloride and incorporate a buffer (e.g., lactate, acetate, gluconate) that is metabolized in vivo to bicarbonate.
Lactated Ringer's (LR): Contains Na+ 130, Cl- 109, K+ 4, Ca2+ 3, and Lactate 28 mEq/L. (Osmolarity 273 mOsm/L).
Plasma-Lyte A: Contains Na+ 140, Cl- 98, K+ 5, Mg2+ 3, Acetate 27, and Gluconate 23 mEq/L. (Osmolarity 294 mOsm/L).
Advantages: Multiple large, randomized controlled trials (e.g., SMART, SALT-ED, BaSICS) have demonstrated that the use of balanced crystalloids for large-volume resuscitation is associated with a lower incidence of major adverse kidney events (MAKE-30), including a reduced need for new renal replacement therapy, and potentially improved mortality compared to NS, particularly in patients with sepsis.
Disadvantages: LR is slightly hypotonic (273 mOsm/L) and can theoretically worsen cerebral edema in TBI. It also contains calcium, which can bind to citrate in blood products (though the clinical significance in rapid transfusions is debated) and is incompatible with certain medications (e.g., ceftriaxone). Plasma-Lyte is more expensive.
Colloids
Colloids contain large molecules (proteins or synthetic polymers) that do not readily cross the semipermeable capillary membrane. They generate colloid osmotic (oncotic) pressure, drawing fluid into and holding it within the intravascular space. Theoretically, smaller volumes of colloids are required to achieve the same hemodynamic endpoints as crystalloids.
Albumin
Albumin is a naturally occurring plasma protein. It is available in 4%, 5%, and 25% concentrations. For resuscitation, the 4% or 5% (iso-oncotic) solutions are used. The 25% (hyper-oncotic) solution is used primarily for fluid restriction or specific disease states (e.g., large-volume paracentesis, hepatorenal syndrome).
Clinical Role: The SAFE trial demonstrated that albumin and saline resulted in similar 28-day mortality in a general ICU population. However, a post-hoc analysis suggested a potential mortality benefit in patients with severe sepsis and potential harm in patients with traumatic brain injury. The Surviving Sepsis Campaign guidelines suggest using albumin in patients requiring substantial amounts of crystalloids.
Considerations: Albumin is a blood product, carries a small risk of anaphylaxis, and is significantly more expensive than crystalloids.
Synthetic Colloids
Hydroxyethyl Starches (HES): These are synthetic polymers of glucose. Large randomized trials (e.g., CHEST, 6S) conclusively demonstrated that HES solutions increase the risk of acute kidney injury, the need for renal replacement therapy, and mortality in critically ill patients, especially those with sepsis. HES solutions carry a black box warning and are generally contraindicated in critically ill patients.
Gelatins and Dextrans: These are less commonly used in the US. Dextrans can interfere with blood cross-matching and cause coagulopathy and acute kidney injury.
Clinical Scenario
Consider a 65-year-old male admitted to the ICU with septic shock secondary to pneumonia. His blood pressure is 75/40 mmHg, heart rate is 125 bpm, and lactate is 4.5 mmol/L. He requires aggressive fluid resuscitation.
Based on current evidence and guidelines, a balanced crystalloid (such as Lactated Ringer's or Plasma-Lyte) is the fluid of choice for initial resuscitation. Administering large volumes of 0.9% sodium chloride in this scenario would significantly increase his risk of developing hyperchloremic metabolic acidosis and acute kidney injury. If he requires massive amounts of crystalloid (e.g., > 3-4 liters) and remains hemodynamically unstable, the addition of 5% albumin could be considered to augment intravascular volume while limiting total fluid balance and avoiding excessive crystalloid-induced tissue edema. Hydroxyethyl starch (HES) should be strictly avoided due to the high risk of renal injury and mortality in sepsis.